Literature DB >> 33664959

The diagnostic challenge of pneumocystis pneumonia and COVID-19 co-infection in HIV.

Alistair G B Broadhurst1, Usha Lalla2, Jantjie J Taljaard3, Elizabeth H Louw2, Coenraad F N Koegelenberg2, Brian W Allwood2.   

Abstract

Coronavirus disease 2019 (COVID-19) and pneumocystis pneumonia (PCP) share many overlapping features and may be clinically indistinguishable on initial presentation in people living with HIV. We present the case of co-infection with COVID-19 and PCP in a patient with progressive respiratory failure admitted to our intensive care unit where the dominant disease was uncertain. This case highlights the difficulty in differentiating between the two diseases, especially in a high HIV prevalence setting where PCP is frequently diagnosed using case definitions and clinical experience due to limited access to bronchoscopy, appropriate laboratory testing, and computed tomography scans. In addition, diagnostic testing may yield false-negative results in both diseases, and clinician awareness to the overlap and pitfalls is essential if COVID-19 becomes endemic in such settings.
© 2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.

Entities:  

Keywords:  COVID‐19; HIV; SARS‐CoV‐2; pneumocystis pneumonia

Year:  2021        PMID: 33664959      PMCID: PMC7900711          DOI: 10.1002/rcr2.725

Source DB:  PubMed          Journal:  Respirol Case Rep        ISSN: 2051-3380


  13 in total

Review 1.  Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection.

Authors:  Jeffrey P Kanne; Donald R Yandow; Cristopher A Meyer
Journal:  AJR Am J Roentgenol       Date:  2012-06       Impact factor: 3.959

2.  Pneumocystis carinii pneumonia diagnosed by non-induced sputum stained with a direct fluorescent antibody.

Authors:  A L Rafanan; P Klevjer-Anderson; M L Metersky
Journal:  Ann Clin Lab Sci       Date:  1998 Mar-Apr       Impact factor: 1.256

3.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens.

Authors:  Wenling Wang; Yanli Xu; Ruqin Gao; Roujian Lu; Kai Han; Guizhen Wu; Wenjie Tan
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

4.  HIV and SARS-CoV-2 co-infection: The diagnostic challenges of dual pandemics.

Authors:  A Parker; J Shaw; S Karamchand; S Lahri; N Schrueder; M-Y Chothia; A Mowlana; U Lalla; B W Allwood; C F N Koegelenberg; J J Taljaard
Journal:  S Afr Med J       Date:  2020-04-30

5.  Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.

Authors:  David Kim; James Quinn; Benjamin Pinsky; Nigam H Shah; Ian Brown
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

6.  Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia.

Authors:  E K Sage; M Noursadeghi; H E Evans; S J Parker; A J Copas; S G Edwards; R F Miller
Journal:  Int J STD AIDS       Date:  2010-04       Impact factor: 1.359

7.  Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.

Authors: 
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

8.  Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.

Authors:  Sana Salehi; Aidin Abedi; Sudheer Balakrishnan; Ali Gholamrezanezhad
Journal:  AJR Am J Roentgenol       Date:  2020-03-14       Impact factor: 3.959

9.  Diagnostic value of direct fluorescence antibody staining for detecting Pneumocystis jirovecii in expectorated sputum from patients with HIV infection.

Authors:  Pyoeng Gyun Choe; Yoo Min Kang; Gayeon Kim; Wan Beom Park; Sang Won Park; Hong Bin Kim; Myoung-Don Oh; Eui Chong Kim; Nam Joong Kim
Journal:  Med Mycol       Date:  2014-03-25       Impact factor: 4.076

10.  Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.

Authors:  Alfonso J Rodriguez-Morales; Jaime A Cardona-Ospina; Estefanía Gutiérrez-Ocampo; Rhuvi Villamizar-Peña; Yeimer Holguin-Rivera; Juan Pablo Escalera-Antezana; Lucia Elena Alvarado-Arnez; D Katterine Bonilla-Aldana; Carlos Franco-Paredes; Andrés F Henao-Martinez; Alberto Paniz-Mondolfi; Guillermo J Lagos-Grisales; Eduardo Ramírez-Vallejo; Jose A Suárez; Lysien I Zambrano; Wilmer E Villamil-Gómez; Graciela J Balbin-Ramon; Ali A Rabaan; Harapan Harapan; Kuldeep Dhama; Hiroshi Nishiura; Hiromitsu Kataoka; Tauseef Ahmad; Ranjit Sah
Journal:  Travel Med Infect Dis       Date:  2020-03-13       Impact factor: 6.211

View more
  4 in total

1.  Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.

Authors:  Elisabeth A Merchant; Kristen Flint; Dan H Barouch; Barbra M Blair
Journal:  IDCases       Date:  2021-05-07

Review 2.  Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals.

Authors:  Francesca Gioia; Hanan Albasata; Seyed M Hosseini-Moghaddam
Journal:  J Fungi (Basel)       Date:  2022-05-30

Review 3.  The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.

Authors:  Nahid Akhtar; Atif Khurshid Wani; Surya Kant Tripathi; Ajit Prakash; M Amin-Ul Mannan
Journal:  Curr Res Biotechnol       Date:  2022-08-03

4.  COVID-19 and Fungal Infections: A Double Debacle.

Authors:  Sara Mina; Hajar Yaakoub; Cédric Annweiler; Vincent Dubée; Nicolas Papon
Journal:  Microbes Infect       Date:  2022-08-24       Impact factor: 9.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.